Lpl Financial LLC Intellia Therapeutics, Inc. Transaction History

Lpl Financial LLC

$320 Billion
Q3 2025

A detailed history of Lpl Financial LLC transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Lpl Financial LLC holds 103,035 shares of NTLA stock, worth $896,404. This represents 0.0% of its overall portfolio holdings.

Number of Shares

103,035

Previous 63,953 61.11%

Holding current value

$896,404

Previous $599,000 196.99%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 12, 2025	BUY	$9.88 - $17.76 $386,130 - $694,096	39,082 Added 61.11%	103,035 $1.78 Million
Q2 2025 Aug 12, 2025	BUY	$6.28 - $9.67 $58,083 - $89,437	9,249 Added 16.91%	63,953 $599,000
Q1 2025 May 07, 2025	BUY	$7.11 - $12.8 $4,713 - $8,486	663 Added 1.23%	54,704 $388,000
Q4 2024 Feb 11, 2025	SELL	$11.41 - $21.09 $29,141 - $53,863	-2,554 Reduced 4.51%	54,041 $630,000
Q3 2024 Nov 08, 2024	SELL	$19.72 - $27.36 $14,415 - $20,000	-731 Reduced 1.28%	56,595 $1.16 Million

Q2 2024 Aug 07, 2024	BUY	$20.02 - $27.22 $114,814 - $156,106	5,735 Added 11.12%	57,326 $1.28 Million
Q1 2024 May 10, 2024	BUY	$23.82 - $32.8 $120,410 - $165,804	5,055 Added 10.86%	51,591 $1.42 Million
Q4 2023 Feb 14, 2024	BUY	$23.16 - $32.34 $40,252 - $56,206	1,738 Added 3.88%	46,536 $1.42 Million
Q3 2023 Nov 13, 2023	BUY	$31.62 - $45.78 $6,924 - $10,025	219 Added 0.49%	44,798 $1.42 Million
Q2 2023 Jul 31, 2023	BUY	$34.58 - $46.03 $207,410 - $276,087	5,998 Added 15.55%	44,579 $1.82 Million
Q1 2023 May 10, 2023	BUY	$33.3 - $44.82 $86,246 - $116,083	2,590 Added 7.2%	38,581 $1.44 Million
Q4 2022 Feb 07, 2023	SELL	$33.21 - $62.69 $125,400 - $236,717	-3,776 Reduced 9.5%	35,991 $1.26 Million
Q3 2022 Nov 14, 2022	SELL	$53.92 - $71.7 $110,859 - $147,415	-2,056 Reduced 4.92%	39,767 $2.23 Million
Q2 2022 Aug 12, 2022	BUY	$38.49 - $76.21 $35,102 - $69,503	912 Added 2.23%	41,823 $2.17 Million
Q1 2022 May 16, 2022	SELL	$58.27 - $118.99 $217,463 - $444,070	-3,732 Reduced 8.36%	40,911 $2.97 Million
Q4 2021 Feb 14, 2022	BUY	$100.76 - $138.36 $89,777 - $123,278	891 Added 2.04%	44,643 $5.28 Million
Q3 2021 Nov 15, 2021	BUY	$132.37 - $176.78 $240,516 - $321,209	1,817 Added 4.33%	43,752 $5.87 Million
Q2 2021 Aug 13, 2021	SELL	$60.88 - $161.91 $719,966 - $1.91 Million	-11,826 Reduced 22.0%	41,935 $6.79 Million
Q1 2021 May 14, 2021	BUY	$46.59 - $83.68 $487,051 - $874,790	10,454 Added 24.14%	53,761 $4.32 Million
Q4 2020 Feb 12, 2021	BUY	$18.83 - $63.53 $234,621 - $791,583	12,460 Added 40.39%	43,307 $2.36 Million
Q3 2020 Nov 09, 2020	BUY	$17.47 - $24.93 $76,972 - $109,841	4,406 Added 16.66%	30,847 $613,000
Q2 2020 Aug 13, 2020	BUY	$11.14 - $22.87 $160,516 - $329,533	14,409 Added 119.76%	26,441 $556,000
Q1 2020 May 14, 2020	BUY	$9.44 - $15.58 $113,582 - $187,458	12,032 New	12,032 $147,000

Others Institutions Holding NTLA

# of Institutions

343

Shares Held

103M

Call Options Held

3.16M

Put Options Held

1.56M

View Full List

About Intellia Therapeutics, Inc.

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $661M
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

More about NTLA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.

Account

Lpl Financial LLC Intellia Therapeutics, Inc. Transaction History